BioAmber (BIOA) Tops Q3 EPS by 14c

BioAmber (NYSE: BIOA) reported Q3 EPS of ($0.27), $0.14 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $300 thousand versus the consensus estimate of $2.3 million.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Black Rock Coffee Bar, Inc. (BRCB) Misses Q2 EPS by 1c
• Erasca, Inc. (ERAS) Misses Q2 EPS by 3c